Statins, systemic inflammation and risk of death in COPD: the Rotterdam study.

@article{Lahousse2013StatinsSI,
  title={Statins, systemic inflammation and risk of death in COPD: the Rotterdam study.},
  author={Lies Lahousse and Daan Willem Loth and Guy F Joos and Albert Hofman and Hubert Gerardus Maria Leufkens and Guy Gaston Brusselle and Bruno H. C. Stricker},
  journal={Pulmonary pharmacology & therapeutics},
  year={2013},
  volume={26 2},
  pages={212-7}
}
BACKGROUND Studies suggest that statins decrease mortality in COPD patients but it is unknown which patients might benefit most. OBJECTIVES We investigated whether statins were associated with reduced mortality in COPD patients and whether effects differed according to baseline high-sensitivity C-reactive protein (hsCRP) concentration, a marker of systemic inflammation. METHODS This nested case-control study was part of the Rotterdam Study, a prospective population-based cohort study among… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

Inflammatory status and lung function predict mortality in lung cancer screening participants

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation • 2018

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society • 2017

Screening for COPD: the gap between logic and evidence.

European respiratory review : an official journal of the European Respiratory Society • 2017

References

Publications referenced by this paper.
Showing 1-10 of 29 references

C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease

Y van Durme, KMC Verhamme, +3 authors JCM Witteman
Am J Respir Crit Care Med 2009;179:375e82. Please cite this article in press as: Lahousse L, • 2012
View 1 Excerpt

Statin use in COPD patients is associated with a reduction in mortality: a national cohort study.

Primary care respiratory journal : journal of the General Practice Airways Group • 2012
View 1 Excerpt

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study

J Emberson, D Bennett, +3 authors J Armitage
Lancet 2011;377:469e76 • 2011
View 2 Excerpts

Pharmacological actions of statins: potential utility in COPD.

European respiratory review : an official journal of the European Respiratory Society • 2009
View 1 Excerpt

Similar Papers

Loading similar papers…